Medical Search Engine for General Practitioners in France

Convera Corporation (NASDAQ: CNVR), a leading provider of search technologies for publishers, announced the launch of SearchMedica France. The specialized search engine, built for doctors in France, was developed by CMPMedica, Convera and medical experts from Le Quotidien du Médecin, a popular daily medical journal published by CMPMedica. CMPMedica, a division of UBM plc, is a global provider of healthcare information and education.

SearchMedica France provides specialized access to well-respected medical Web sites, professional journals and clinical resources. The site also enables medical professionals to search CMPMedica's proprietary Vidal database of information on 3,500 pharmaceuticals. Search results are organized by distinct medical categories, which were developed by working closely with doctors in real-life working conditions.

"As medical professionals increasingly turn to the Web for critical information, CMPMedica has developed the right prescription for vertical search," said Patrick Condo, Convera's chief executive officer. "SearchMedica France provides a way to search the Web for highly relevant content that professionals can trust and offers access to proprietary editorial content that is not published on the Web. It's a search engine built for doctors, tested by them and backed by strongly positive reviews."

SearchMedica France expands CMPMedica's vertical search solutions for medical professions and strengthens the SearchMedica brand. CMPMedica has teamed with Convera to launch SearchMedica sites for UK general practitioners as well as U.S. primary care providers and psychiatrists. CMPMedica is looking to develop further search solutions for healthcare professionals in other specialties and countries.

For further information, please visit:
www.searchmedica.fr

About Convera®
Convera® is a leading provider of search technologies for professional workers. Convera has developed a unified product platform that makes sense of vast amounts of information—wherever it resides—across multiple data formats, languages and meanings. Based on proprietary technologies that extract relevant results from public and private data, Convera enables professionals to quickly retrieve exactly the information essential for action. The Convera search platform, TrueKnowledge Platform™, is delivered as a hosted service, software or a bundled hardware and software package. Thousands of government and business professionals in 40 countries rely on Convera search solutions to power a broad range of mission critical applications. For more information, visit www.convera.com

About CMPMedica
CMPMedica, a division of United Business Media plc, provides healthcare information and education to primary care physicians, specialists, pharmacists and patients around the world. Providing journals, magazines, directories, drug databases, other electronic databases, Web sites, face-to-face meetings and other valuable resources, CMPMedica also delivers comprehensive communication solutions for the pharmaceutical and related industries. Employing more than 1,400 people with offices in 29 countries, CMPMedica is headquartered in London. In the U.S., CMPMedica provides comprehensive continuing medical education for medical professionals across a wide range of specialties; SearchMedica.com, a unique medical search engine built by doctors for doctors that indexes medicine's most credible sources to provide fast and clinically relevant results; and three publishing divisions - the Cliggott Group, the Newsmagazines Group and the Oncology Group, which collectively publish fourteen of the best read U.S. clinical publications. For more information, visit CMPMedica.com.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

A Machine Learning Tool for Diagnosing, …

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer and healthy people. The analysis...

Fine-Tuned LLMs Boost Error Detection in…

A type of artificial intelligence (AI) called fine-tuned large language models (LLMs) greatly enhances error detection in radiology reports, according to a new study published in Radiology, a journal of...

DeepSeek-R1 Offers Promising Potential t…

A joint research team from The Hong Kong University of Science and Technology and The Hong Kong University of Science and Technology (Guangzhou) has published a perspective article in MedComm...

Deep Learning can Predict Lung Cancer Ri…

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS 2025 International Conference...